PF-07081532
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for PF-07081532, covering 2024-02-05 to 2024-12-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range [Phase 1]